Repression of caspase-3 and RNA-binding protein HuR cleavage by cyclooxygenase-2 promotes drug resistance in oral squamous cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Repression of caspase-3 and RNA-binding protein HuR cleavage by cyclooxygenase-2 promotes drug resistance in oral squamous cell carcinoma

Published:2016-12-12 Issue:22 Volume:36 Page:3137-3148
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Janakiraman H,House R P,Talwar S,Courtney S M,Hazard E S,Hardiman G,Mehrotra S,Howe P H,Gangaraju V,Palanisamy V

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

https://www.nature.com/articles/onc2016451.pdf

Reference51 articles.

1. Bombard Y, Bach PB, Offit K . Translating genomics in cancer care. J Natl Compr Canc Netw 2013; 11: 1343–1353.

2. Brody JR, Gonye GE . HuR's role in gemcitabine efficacy: an exception or opportunity? Wiley interdisciplinary reviews RNA 2011; 2: 435–444.

3. Williams TK, Costantino CL, Bildzukewicz NA, Richards NG, Rittenhouse DW, Einstein L et al. pp32 (ANP32A) expression inhibits pancreatic cancer cell growth and induces gemcitabine resistance by disrupting HuR binding to mRNAs. PloS one 2010; 5: e15455.

4. Costantino CL, Witkiewicz AK, Kuwano Y, Cozzitorto JA, Kennedy EP, Dasgupta A et al. The role of HuR in gemcitabine efficacy in pancreatic cancer: HuR Up-regulates the expression of the gemcitabine metabolizing enzyme deoxycytidine kinase. Cancer Res 2009; 69: 4567–4572.

5. Filippova N, Yang X, Wang Y, Gillespie GY, Langford C, King PH et al. The RNA-binding protein HuR promotes glioma growth and treatment resistance. Molecular cancer research: MCR 2011; 9: 648–659.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNA-binding protein HuR reprograms immune T cells and promotes oral squamous cell carcinoma;Oral Oncology Reports;2024-06

2. RNA binding proteins in cancer chemotherapeutic drug resistance;Frontiers in Cell and Developmental Biology;2024-01-24

3. Feline SCCs of the Head and Neck Display Partial Epithelial-Mesenchymal Transition and Harbor Stem Cell-like Cancer Cells;Pathogens;2023-10-27

4. Relationship between HuR and tumor drug resistance;Clinical and Translational Oncology;2023-03-22

5. Targeting the “undruggable”: RNA-binding proteins in the spotlight in cancer therapy;Seminars in Cancer Biology;2022-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3